A-listers provide a $50M B round to AstraZeneca’s antibiotics spinout Entasis

John Carroll Last summer, AstraZeneca formally spun out its pared-down early-stage antibiotics unit in Waltham, MA, as Entasis Therapeutics, bequeathing a $ 40 million A round for ...

Backed by Novartis and Orbimed, Adicet joins immunotherapy crowd with $51M round

John Carroll Adicet Bio has jumped out of stealth mode–more or less–with a $ 51 million A round and plans to combine two platform technologies into a next-gen approach ...

Crossovers fund a $61M round for Twist Bio, spotlighting possible IPO

John Carroll Just 7 months after coming up with a $ 37 million Series C, Twist Bioscience has gone back to the well and drawn up another $ 61 million in private investor cash. That ...

Ysios, J&J back €11.5M round in Aelix to fund trials of HIV treatment

Nick Paul Taylor Aelix Therapeutics has raised €11.5 million ($ 12.6 million) to advance a therapeutic HIV candidate to clinical proof of concept. Ysios Capital, Johnson & ...

Kodiak bags a $34M B round for retinal R&D

Damian Garde Ophthalmology biotech Kodiak Sciences raised $ 34 million in Series B financing to speed up its pipeline of ocular therapies. FierceBiotech News

M&A: Buckle your seat belts for another big round of deals

John Carroll With valuations down, buyouts and licensing deals become even more attractive. They're already a requirement. Anyone with a casual acquaintance with the state of Big ...

With Big Pharma backing, eFFECTOR plots solid tumor trial with $40M round

John Carroll More than two years after landing a hefty launch round, San Diego-based eFFECTOR Therapeutics has scooped up a $ 40 million financing from an expanded group of investors, ...

With Roche in the rear view mirror, Constellation Pharma grabs $55M round

John Carroll FierceBiotech News

Lilly backs a $25M round for anti-inflammatory startup Symic

Damian Garde San Francisco's Symic raised $ 25 million to fund its work on a pair of anti-inflammatory medicines targeting the extracellular matrix, recruiting Eli Lilly to lead ...

Roche backs €19M CNS round; CRUK puts £20M into cancer vax; In womb stem cell trial to start

Nick Paul Taylor In this week's EuroBiotech Report, Ysios Capital led a €19.4 million ($ 21.7 million) investment in Minoryx Therapeutics with the support of Roche Venture ...

Deerfield leads a $75M round for Akari

John Carroll FierceBiotech News

Syndax banks an $80M crossover round for PhIII cancer drug

John Carroll Two months after signing up AstraZeneca R&D leader Briggs Morrison as its new CEO, Waltham, MA-based Syndax has raised $ 80 million from a syndicate that includes ...
Page 1 of 612345...Last »
© 2017 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS